Stay current
Showing 0 of 2 items
test jornal 2-20
This recent study concluded that commonly prescribed medications do not appear to alter the efficacy of immune checkpoint inhibitors in stage IV NSCLC, and advises previous associations seen in literature may be due to unmeasured confounding. Please see the attached trial for full details.